Consilium MedicumConsilium Medicum2075-17532542-2170Consilium Medicum93522Research ArticleVliyanie razlichnykh faktorov na effektivnost' samokontrolya pri sakharnom diabeteRed'kinYu. A-BogomolovV. V-151220111312545828122021Copyright © 2011, Consilium Medicum2011[Karter A.J., Ackerson L.M., Darbinian J.A. et al. Self - monitoring of blood glucose levels and glycemic control: the Northern California Kaiser Permanente Diabetes registry. Am J Med 2001; 111: 1–9.][Welschen L, Bloemendal E, Nijpels G et al. Self - monitoring of blood glucose in patients with type 2 diabetes who are not using insulin: a systematic review. Diabetes Care 2005; 28: 1510–7.][Skovlund S.E., Peyrot M, on behalf of the DAWN International Advisory Panel. The Diabetes Attitudes, Wishes, and Needs (DAWN) program: a new approach to improving outcomes of diabetes care. Diabetes Spectrum 2005; 18: 136–42.][Jansen J.P. Self - monitoring of glucose in type 2 diabetes mellitus: a Bayesian meta - analysis of direct and indirect comparisons. Curr Med Res Opin 2006; 22: 671–81.][Heisler M, Piette J.D., Spencer M et al. The relationship between knowledge of recent HbA1c values and diabetes care understanding and self - management. Diabetes Care 2005; 28: 816–22.][American Diabetes Association: Standards of medical care in diabetes-2010. Diabetes Care 2010; 33 (Suppl. 1): S11–S61.][American Association of Diabetes Educators: AADE guidelines for the practice of diabetes self - management education and training (DSME/T) 2009 [article online]; http://www.diabeteseducator.org/export/sites/aade/_resources/pdf/PracticeGuidelines2009.pdf. Accessed 14 March 2010.][Алгоритмы специализированной медицинской помощи больным сахарным диабетом. Под ред. И.И.Дедова, М.В.Шестаковой. Вып. 5. М., 2009.][Davidson P.C. et al. Abstracts from the 64th Scientific Sessions of the American Diabetes Association. Orlando, Florida, 2004; Abstract, p. 430.][Karter A.J., Parker M.M., Moffet H.H. et al. Longitudinal study of new and prevalent use of self - monitoring of blood glucose. Diabetes Care 2006; 29: 1757–63.][Stratton I.M., Adler A.I., Neil A.W. et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ 2000; 321: 405–12.][The DCCT Research Group: The effect of intensive treatment on the development and progression of long - term complications in type 1 diabetes. N Engl J Med 1993; 329: 977–86.][Shichiri M, Kishikawa H, Ohkubo Y, Wake N. Long term results of the Kumamoto study on optimal diabetes control in type 2 diabetic patients. Diabetes Care 2000; 23: B21–B29.][The UKPDS Study Group: Effort of intensive blood glucose control with insulin and sulfonylureas on insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998; 352: 837–53.][The DCCT Research Group: Epidemiology of severe hypoglycemia in the diabetes control and complications trial. Am J Med 1991; 90: 450–9.][Cox D.J., Gonder-Frederick L, Ritterband L et al: Prediction of severe hypoglycemia. Diabetes Care 2007; 30: 1370–3][http://www.iso.org][Newman J.D.; Turner A.P. Home blood glucose biosensors: a commercial perspective. Biosens Bioelectron 2005; 20: 2435–53.][Turner A.P. Biosensors – sense and sensitivity. Science 2000; 290: 1315–7.][Hiratsuka A, Fujisawa K, Muguruma H. Amperometric biosensor based on glucose dehydrogenase and plasma - polymerized thin films. Anal Sci 2008; 24: 483–6.][D\'Costa E.J., Higgins I.J., Turner A.P. Quinoprotein glucose dehydrogenase and its application in an amperometric glucose sensor. Biosensors 1986; 2: 71–87.][Heller A, Feldman B. Electrochemical glucose sensors and their applications in diabetes management. Chem Rev 2008; 108: 2482–505.][Bankar S.B., Bule M.V., Singhal R.S., Ananthanarayan L. Glucose oxidase – an overview. Biotechnol Adv 2009; 27: 489–501.][Yoo E.H., Lee S.Y. Glucose Biosensors: an Overview of Use in Clinical Practice. Sensors 2010; 10: 4558–76.][Institute for Safe Medication Practices, Be aware of false glucose results with point - of - care testing. ISMP Medication Safety Alert! 2005; 10 (18).][Janssen W et al. Positive Interference of Icodextrin metabolites in some enzymatic glucose methods. Clinical Chemistry 1998; 44 (11): 2379–80.][http://www.fda.gov/MedicalDevices/Safety/AlertsandNotices/PatientAlerts/ucm177189.htm][Ellison J.M., Stegmann J.M., Colner S.L. et al. Rapid Changes in Postprandial Blood Glucose Produce Concentration Differences at Finger, Forearm, and Thigh Sampling Sites. Diabetes Care 2002; 25: 961–4.][Bina D.M. et al. Clinical impact of prandial state, exercise, and site preparation on the equivalence of alternative - site blood glucose testing. Diabetes Care 2003; 26: 981–5.][Raine C.H. 3rd Self - monitored blood glucose: a common pitfall. Endocr Pract 2003; 9 (9): 137–9.][Kristensen G.B., Nerhus K, Thue G, Sandberg S. Standardized evaluation of instruments for self - monitoring of blood glucose by patients and a technologist. Clin Chem 2004; 50: 1068–71.][Baum J.M., Monhaut N.M., Parker D.R., Price C.P. Improving the quality of self - monitoring blood glucose measurement: a study in reducing calibration errors. Diabetes Technol Ther 2006; 8: 347–57.][Raine C.H., Schrock L.E., Edelman S.V. et al. Significant insulin dose errors may occur if blood glucose results are obtained from miscoded meters. J Diabetes Sci Technol 2007; 2: 205–10.]